Antimicrobial susceptibility of clinical isolates of aerobic gram-negative bacteria in 2006

Japanese Journal of Antibiotics

Volumn 63, Issue 6, 2010, Pages 457-479

  Yoshida, Isamu ^a   Yamaguchi, Takahiro ^a   Itoh, Yoshihisa ^b   Tachibana, Mineji ^b   Takahashi, Choichiro ^c   Kaku, Mitsuo ^d   Kanemitsu, Keiji ^d,e   Okada, Masahiko ^f   Horikawa, Yoshinori ^f   Shiotani, Joji ^g   Kino, Hiroyoshi ^h   Ono, Yuka ^h   Baba, Hisashi ⁱ   Matsuo, Shuji ^j   Asari, Seishi ^k   Toyokawa, Masahiro ^k   Matsuoka, Kimiko ^l   Kusano, Nobuchika ^m   Nose, Motoko ^m   Murase, Mitsuharu ⁿ   Miyamoto, Hitoshi ⁿ   Saikawa, Tetsunori ^o   Hiramatsu, Kazufumi ^o   Kohno, Shigeru ^p   Yanagihara, Katsunori ^p   Yamane, Nobuhisa ^q   Nakasone, Isamu ^q   Maki, Hideki ^a   Yamano, Yoshinori ^a   more..

^a SHIONOGI AND CO LTD   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c YAMAGATA UNIVERSITY HOSPITAL   (Japan)

^d TOHOKU UNIVERSITY HOSPITAL   (Japan)

^e FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^f NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^g Cancer Institute Hospital   (Japan)

^h MITSUI MEMORIAL HOSPITAL   (Japan)

ⁱ NAGOYA UNIVERSITY HOSPITAL   (Japan)

^j TENRI HOSPITAL   (Japan)

^k OSAKA UNIVERSITY HOSPITAL   (Japan)

^l OSAKA GENERAL MEDICAL CENTER   (Japan)

^m OKAYAMA UNIVERSITY HOSPITAL   (Japan)

ⁿ EHIME UNIVERSITY HOSPITAL   (Japan)

^o OITA UNIVERSITY HOSPITAL   (Japan)

^p NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^q UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CIPROFLOXACIN; DORIPENEM; EXTENDED SPECTRUM BETA LACTAMASE; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEUS; PROTEUS MIRABILIS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE AEROBIC BACTERIA; MICROBIAL SENSITIVITY TESTS;

EID: 79551593051     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. MURRAY, P. R.; E. J. BARON, J. H. JORGENSEN, et al.: Manual of Clinical Microbiology, 8th ed. American Society for Microbiology, Washington, DC, 2003
2. Clinical and Laboratory Standards Institute (CLSI): Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. 6th ed., M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA, 2006
3. Clinical and Laboratory Standards Institute (CLSI): Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement, M100-S17. Clinical and Laboratory Standards Institute (CLSI), Wayne, PA, 2007
4. Chemotherapy 38: 102-105, 1990
5. SHIROTO, K.; Y. ISHII, S. KIMURA, et al.: Metaro-β-lactamase IMP-1 in Providencia rettgeri from two different hospitals in Japan. J. Med. Microbiol. 54: 1065-1070, 2005
6. Jpn. J. Antibiotics 61: 209-240, 2008
7. Jpn. J. Antibiotics 61: 241-268, 2008
8. Jpn. J. Antibiotics 60: 344-377, 2007
9. NIKI, Y.; H. HANAKI, M. YAGISAWA, et al.: The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: a general view of antibacterial susceptibility. J. Infect. Chemother. 14: 279-290, 2008
10. HOTOMI, M.; K. FUJIHARA, A. SAKAI, et al.: Genetic characteristics and clonal dissemination of β-lactamase-negative ampicillin-resistant Haemophilus influenzae strains isolated from the upper respiratory tract of patients in Japan. Antimicrob. Agents Chemother. 51: 3969-3976, 2007
11. Jpn. J. Antibiotics 61: 195-208, 2008
12. CRITCHLEY, I. A.; S. D. BROWN, M. M. TRACZEWSKI, et al.: National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. faropenem surveillance study. Antimicrob. Agents Chemother. 51: 4382-4389, 2007
13. SILL, M. L. & R. S. W. TSANG: Antibiotic susceptibility of invasive Haemophilus influenzae strains in Canada. Antimicrob. Agents Chemother. 52: 1551-1552, 2008
14. GRACIA, M.; C. DIAZ, P. CORONEL, et al.: Antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis isolates in eight Central, East and Baltic European countries in 2005-06: results of the cefditoren surveillance study. J. Antimicrob. Chemother. 61: 1180-1181, 2008
15. GARCIA-COBOS, S.; J. CAMPOS, E. CERCENADO, et al.: Antibiotic resistance in Haemophilus influenzae decreased, except for β-lactamase-negative amoxicillin-resistant isolates, in parallel with community antibiotic consumption in Spain from 1997 to 2007. Antimicrob. Agents Chemother. 52: 2760-2766, 2008
16. TRISTRAM, S. G.; M. J. PITOUT, K. FORWARD, et al.: Characterization of extended-spectrum β-lactamase-producing isolates of Haemophilus parainfluenzae. J. Antimicrob. Chemother. 61: 509-514, 2008
17. Jpn. J. Antibiotics 60: 378-386, 2007
18. ZHANEL, G. G.; M. DECORBY, N. LAING, et al.: Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CANICU) study, 2005-2006. Antimicrob. Agents Chemother. 52: 1430-1437, 2008
19. REINERT, R. R.; D. E. LOW, F. ROSSI, X. ZHANG, et al.: Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J. Antimicrob. Chemother. 60: 1018-1029, 2007
20. PATZER, J. A.; D. DZIERZANOWSKA & P. J. TURNER: Trends in antimicrobial susceptibility of Gram-negative isolates from a paediatric intensive care unit in Warsaw: results from the MYSTIC programme (1997-2007). J. Antimicrob. Chemother. 62: 369-375, 2008
21. KO, K. S.; M. Y. LEE, J. H. SONG, et al.: Prevalence and characterization of extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Korean hospitals. Diagn. Microbiol. Infect. Dis. 61: 453-459, 2008
22. GUTIERREZ, O.; C. JUAN, E. CERCENADO, et al.: Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob. Agents Chemother. 51: 4329-4335, 2007
23. TURNER, P. J.: Meropenem activity against European isolates: report on the MYSTIC (meropenem yearly susceptibility test information collection) 2006 results. Diagn. Microbiol. Infect. Dis. 60: 185-192, 2008
24. JONES, R. N.; J. T. KIRBY, P. R. RHOMBERG: Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance. Diagn. Microbiol. Infect. Dis. 61: 203-213, 2008
25. ZHANEL, G. G.; M. DECORBY, K. A. NICHOL, et al.: Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006. Diagn. Microbiol. Infect. 62: 67-80, 2008
26. KIRIKAE, T.; Y. MIZUGUCHI, Y. ARAKAWA: Investigation of isolation rates of Pseudomonas aeruginosa with and without multidrug resistance in medical facilities and clinical laboratories in Japan. J. Antimicrob. Chemother. 61: 612-615, 2008
27. LOCKHART, S. R.; M. A. ABRAMSON, S. E. BEEKMANN, et al.: Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J. Clin. Microbiol. 45: 3352-3359, 2007